Using Medical Cannabis for Chronic Pain: A Social-Ecological Framework.
暂无分享,去创建一个
[1] E. Mcginty,et al. Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs , 2023, JAMA network open.
[2] Zina Zaslawski,et al. Medical cannabis in schools: A qualitative study on the experiences of clinicians , 2022, Paediatrics & child health.
[3] H. Flynn,et al. Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use , 2022, Substance use & misuse.
[4] P. Zimbrean,et al. Cannabinoids and solid organ transplantation: Psychiatric perspectives and recommendations. , 2022, Transplantation reviews.
[5] R. Pollini,et al. “The DEA would come in and destroy you”: a qualitative study of fear and unintended consequences among opioid prescribers in WV , 2022, Substance Abuse Treatment, Prevention, and Policy.
[6] P. Peretti-Watel,et al. 'I trust them because my mum trusts them': Exploring the role of trust in HPV vaccination decision-making among adolescent girls and their mothers in France. , 2022, Vaccine.
[7] A. Wilson-Poe,et al. Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain , 2021, Cannabis and cannabinoid research.
[8] Liangcheng Yang,et al. A narrative review on environmental impacts of cannabis cultivation , 2021, Journal of Cannabis Research.
[9] A. Vigano,et al. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process , 2021, Journal of Cannabis Research.
[10] V. K. Mahabir,et al. Comparing medical cannabis use in 5 US states: a retrospective database study , 2021, Journal of Cannabis Research.
[11] J. Whitehill,et al. Edible Cannabis Exposures Among Children: 2017–2019 , 2021, Pediatrics.
[12] L. Phillips,et al. A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products , 2021, Cannabis and cannabinoid research.
[13] W. Hall,et al. Cannabis use and cannabis use disorder , 2021, Nature Reviews Disease Primers.
[14] K. Boehnke,et al. Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution , 2021, Journal of Cannabis Research.
[15] Shane R Mueller,et al. Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose. , 2021, The International journal on drug policy.
[16] Z. Walsh,et al. Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study. , 2020, Pain medicine.
[17] H. Johal,et al. Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis. , 2020, Cannabis and cannabinoid research.
[18] Matthew Reid. A qualitative review of cannabis stigmas at the twilight of prohibition , 2020, Journal of Cannabis Research.
[19] V. K. Mahabir,et al. Medical cannabis use in the United States: a retrospective database study , 2020, Journal of Cannabis Research.
[20] R. Pollini,et al. Assessing the impact of a restrictive opioid prescribing law in West Virginia , 2020, Substance Abuse Treatment, Prevention, and Policy.
[21] R. Isralowitz,et al. Does religiosity matter? University student attitudes and beliefs toward medical cannabis. , 2020, Complementary therapies in medicine.
[22] David A. Williams,et al. High frequency medical cannabis use is associated with worse pain among individuals with chronic pain. , 2020, The journal of pain : official journal of the American Pain Society.
[23] E. Lombardi,et al. Ohio physician attitudes toward medical Cannabis and Ohio’s medical marijuana program , 2020, Journal of Cannabis Research.
[24] Z. Walsh,et al. The Medical Cannabis Standards Engagement Evaluation and Dissemination (SEED) project: A community-based research approach to self-regulating medical cannabis dispensaries in Canada. , 2020, The International journal on drug policy.
[25] L. C. Bidwell,et al. Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data. , 2019, Cannabis and cannabinoid research.
[26] S. Vulfsons,et al. Predicting Physicians' Intentions to Recommend Medical Cannabis. , 2019, Journal of pain and symptom management.
[27] K. Humphreys,et al. Association between medical cannabis laws and opioid overdose mortality has reversed over time , 2019, Proceedings of the National Academy of Sciences.
[28] L. Squeglia,et al. Medical Cannabis Use among Adults in the Southeastern United States. , 2019, Cannabis.
[29] Michelle Newhart. The Medicalization of Marijuana , 2018 .
[30] I. Grant,et al. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993–2014 , 2018, Addiction.
[31] G. Newton-Howes. The challenges of 'medical cannabis' and mental health: a clinical perspective. , 2018, British journal of clinical pharmacology.
[32] A. Abraham,et al. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population , 2018, JAMA internal medicine.
[33] L. Radbruch,et al. Cannabis-based medicines for chronic neuropathic pain in adults. , 2018, The Cochrane database of systematic reviews.
[34] E. Iverson,et al. Becoming a medical marijuana user. , 2018, The International journal on drug policy.
[35] E. Romero-Sandoval,et al. Cannabis and Cannabinoids for Chronic Pain , 2017, Current Rheumatology Reports.
[36] Virginia T. LeBaron,et al. The use of cannabis in response to the opioid crisis: A review of the literature. , 2017, Nursing outlook.
[37] N. Haug,et al. Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients. , 2017, Addictive behaviors.
[38] B. Piper,et al. Chronic pain patients' perspectives of medical cannabis , 2017, Pain.
[39] A. Reiman,et al. Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report , 2017, Cannabis and cannabinoid research.
[40] Brian Johnson,et al. Cannabis and Pain: A Clinical Review , 2017, Cannabis and cannabinoid research.
[41] Nehama Lewis,et al. You Brought it on Yourself: The Joint Effects of Message Type, Stigma, and Responsibility Attribution on Attitudes Toward Medical Cannabis , 2017 .
[42] Z. Walsh,et al. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. , 2017, The International journal on drug policy.
[43] B. Betz-Stablein,et al. Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis , 2017, Neuropsychopharmacology.
[44] D. Clauw,et al. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. , 2016, The journal of pain : official journal of the American Pain Society.
[45] C. Cuttler,et al. A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy , 2016, Cannabis and cannabinoid research.
[46] Robert Kay,et al. Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. , 2016, Drug and alcohol review.
[47] Penny F Whiting,et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. , 2015, JAMA.
[48] Michael Krawitz. Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates. , 2015, AMA journal of ethics.
[49] Roland S. Moore,et al. Stigma among California’s Medical Marijuana Patients , 2015, Journal of psychoactive drugs.
[50] C. Cunningham,et al. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. , 2014, JAMA internal medicine.
[51] Joseph Gregorio. Physicians, medical marijuana, and the law. , 2014, The virtual mentor : VM.
[52] Joan L Bottorff,et al. Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study , 2013, Harm Reduction Journal.
[53] M. Côte,et al. Resilience thinking meets social theory , 2012 .
[54] Willi Haas,et al. Sustainable Hospitals: A Socio-Ecological Approach , 2011 .
[55] D. Cichewicz. Synergistic interactions between cannabinoid and opioid analgesics. , 2004, Life sciences.
[56] D. Stokols. Translating Social Ecological Theory into Guidelines for Community Health Promotion , 1996, American journal of health promotion : AJHP.
[57] Michelle M. Gilmore,et al. Cannabis and the Environment: What Science Tells Us and What We Still Need to Know , 2021 .
[58] M. Hannan,et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[59] R. Byyny. The social determinants of health. , 2012, The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha.
[60] O. Nelson,et al. The Health Effects of Cannabis and Cannabinoids : The Current State of Evidence and Recommendations for Research Committee on the Health Effects of Marijuana : An Evidence , 2017 .